Abstract
Neuraxial modulation therapies, such as stellate ganglion block, thoracic epidural anaesthesia, and cardiac sympathetic denervation, are effective for ventricular arrhythmias. However, these treatments can increase the risk of bleeding and infection. In this case report, stellate ganglion phototherapy was safely and effectively performed for refractory ventricular tachycardias in a patient with a history of left ventricular assist device implantation. Stellate ganglion phototherapy may have the potential to treat refractory ventricular arrhythmias as an additive therapy or bridge therapy.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Adult
-
Anticoagulants / therapeutic use
-
Bundle-Branch Block* / diagnosis
-
Bundle-Branch Block* / etiology
-
Cardiac Resynchronization Therapy / methods
-
Cardiomyopathy, Dilated / complications
-
Cardiovascular Agents / therapeutic use
-
Defibrillators, Implantable
-
Drug Resistance
-
Electric Countershock / methods
-
Electrocardiography / methods
-
Heart Failure / etiology
-
Heart Failure / therapy
-
Heart Transplantation
-
Heart-Assist Devices
-
Humans
-
Lasers, Semiconductor / therapeutic use*
-
Male
-
Phototherapy* / instrumentation
-
Phototherapy* / methods
-
Preoperative Period
-
Risk Adjustment / methods
-
Stellate Ganglion* / physiopathology
-
Stellate Ganglion* / radiation effects
-
Tachycardia, Ventricular* / diagnosis
-
Tachycardia, Ventricular* / etiology
-
Tachycardia, Ventricular* / therapy
-
Treatment Outcome
Substances
-
Anticoagulants
-
Cardiovascular Agents